Mirum Pharmaceuticals, Inc. (MIRM) vs Oruka Therapeutics, Inc. (ORKA)
- Mirum Pharmaceuticals, Inc. MIRM 80.18 −2.68%
- Oruka Therapeutics, Inc. ORKA 71.93 −2.63%
Mirum Pharmaceuticals, Inc. and Oruka Therapeutics, Inc. are both Biotechnology companies. Mirum Pharmaceuticals, Inc. and Oruka Therapeutics, Inc. are of similar size ($5.4B and $4.9B). Oruka Therapeutics, Inc. has the higher net margin (0.00% vs −139.2%) and the higher return on invested capital (−40.2% vs −173.0%). Across the 13 metrics below, Oruka Therapeutics, Inc. leads on 9 and Mirum Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | MIRM | ORKA | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 0.00% | 65.16% |
| Operating margin | (134.93%) | 0.00% | 0.00% |
| Net margin | (139.18%) | 0.00% | 0.00% |
| Free cash flow margin | (44.29%) | 0.00% | 0.00% |
| Return on equity | (702.97%) | (18.30%) | (56.36%) |
| Return on assets | (97.15%) | (17.76%) | (48.04%) |
| Return on invested capital | (172.96%) | (40.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack